4//SEC Filing
Sakoda Jon 4
Accession 0001209191-18-031987
CIK 0001325879other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:26 PM ET
Size
10.3 KB
Accession
0001209191-18-031987
Insider Transaction Report
Form 4
Sakoda Jon
10% Owner
Transactions
- Purchase
Common Stock
2018-05-18$2.14/sh+20,100$42,928→ 17,558,822 total(indirect: See Note 2) - Purchase
Common Stock
2018-05-17$2.13/sh+184,179$391,436→ 17,538,722 total(indirect: See Note 2) - Purchase
Common Stock
2018-05-21$2.14/sh+32,200$69,059→ 17,591,022 total(indirect: See Note 2)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.095 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The Reporting Person is a manager of NEA 15 GP, LLC, ("NEA 15 GP") which is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. ("NEA 15"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC ("GEO IV"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeother
Related Parties
1- filerCIK 0001589961
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:26 PM ET
- Size
- 10.3 KB